Acute Ischemic Stroke — Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke
Citation(s)
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of the Aureva Transcranial Ultrasound Device With Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke (TRUST)